FST.L Regulatory News (FST)

16 February 2012

Toumaz Limited

Completion of Placing

On 13 February 2012, Toumaz Limited (AIM: TMZ, 'Toumaz'), a pioneer in low cost, ultra low power wireless communications and broadcast technology, raised £11.2m through a placing ('Placing') of 128,000,001 new ordinary shares of 0.25p ('Placing Shares') with institutional investors at a price of 8.75p per share ('Placing Price').

The Placing Shares were today admitted to trading, and commenced trading, on the AIM market of the London Stock Exchange plc ('AIM').

The admission of the 57,142,857 new Ordinary Shares in Toumaz (the 'Exchange Shares') to Imagination Technologies Group plc (LSE:IMG, 'Imagination') which, as announced on 13 February 2012, was expected to take place today pursuant to the exchange of Imagination's 25% holding in Toumaz Microsystems for 57,142,857 new Ordinary Shares of Toumaz at the Placing Price, has been delayed. An announcement confirming the admission of the Exchange Shares will be made by the Company in due course. 

The Company's total issued share capital is 757,437,869 Ordinary Shares. Toumaz holds no shares in treasury. Therefore, the total number of voting rights in Toumaz is 757,437,869.

The above figure 757,437,869 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, Toumaz under the FSA's Disclosure and Transparency Rules.

Enquiries:

About Toumaz - (www.toumaz.com)

Toumaz is pioneering low cost, ultra-low power wireless technologies for a wide range of markets including medical monitoring and internet-connected consumer devices.

The Group has two businesses; Toumaz UK covering health technology solutions, and Toumaz Microsystems covering the design and development of semiconductor chips and solutions for low power wireless communication.

Toumaz UK provides wireless healthcare monitoring solutions for the hospital and home health markets. Toumaz's licensable smart sensor interface and transceiver platform, Sensium, is a leader in real-time wireless monitoring of the body's vital signs. Sensium has the potential to transform medical monitoring and reduce the cost of healthcare by wirelessly connecting individuals to healthcare providers - simply, affordably and unobtrusively. For healthcare professionals, this creates new opportunities for pro-active monitoring and improved quality of care. For patients, it delivers new opportunities for lifestyle-compatible personalised healthcare.

Toumaz Microsystems designs, develops and sells semiconductor chips and solutions for the growing embedded wireless connectivity market, addressing opportunities in a wide range of internet connected devices. These include home and enterprise automation, healthcare, smart power, security/monitoring systems, intelligent toys and other connectivity-centric cloud-enabled systems. Its key product, Telran, the world's lowest power radio system-on-chip forms the basis for Toumaz UK 's Sensium platform.

Toumaz is an AIM listed company (AIM: TMZ) with development centres in Abingdon, UK and Taipei City, Taiwan.